Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.
Radiat Oncol. 2017 Oct 2;12(1):161. doi: 10.1186/s13014-017-0896-7.
Whole-brain radiation therapy (WBRT) with hippocampus sparing (HS) has been investigated by the radiation oncology working group (RTOG) 0933 trial for patients with multiple brain metastases. They showed a decrease of adverse neurocognitive effects with HS WBRT compared to WBRT alone. With the development of automated treatment planning system (aTPS) in the last years, a standardization of the plan quality at a high level was achieved. The goal of this study was to evaluate the feasibility of using an aTPS for the treatment of HS WBRT and see if the RTOG 0933 dose constraints could be achieved and improved.
Ten consecutive patients treated with HS WBRT were enrolled in this study. 10 × 3 Gy was prescribed according to the RTOG 0933 protocol to 92% of the target volume (whole-brain excluding the hippocampus expanded by 5 mm in 3-dimensions). In contrast to RTOG 0933, the maximum allowed point dose to normal brain was significantly lowered and restricted to 36.5 Gy. All patients were planned with volumetric modulated arc therapy (VMAT) technique using four arcs. Plans were optimized using Auto-Planning (AP) (Philips Radiation Oncology Systems) with one single AP template and optimization.
All the constraints from the RTOG 0933 trial were achieved. A significant improvement for the maximal dose to 2% of the brain with a reduction of 4 Gy was achieved (33.5 Gy vs. RTOG 37.5 Gy) and the minimum hippocampus dose was reduced by 10% (8.1 Gy vs. RTOG 9 Gy). A steep dose gradient around the hippocampus was achieved with a mean dose of 27.3 Gy at a distance between 0.5 cm and 1 cm from the hippocampus. The effective working time to optimize a plan was kept below 6'.
Automated treatment planning for HS WBRT was able to fulfil all the recommendations from the RTOG 0933 study while significantly improving dose homogeneity and decreasing unnecessary hot spot in the normal brain. With this approach, a standardization of plan quality was achieved and the effective time required for plan optimization was minimized.
放射肿瘤学工作组(RTOG)0933 试验研究了全脑放疗(WBRT)联合海马保护(HS)治疗多发性脑转移患者。结果表明,与单纯 WBRT 相比,HS-WBRT 可降低不良神经认知效应。随着近年来自动化治疗计划系统(aTPS)的发展,计划质量达到了高标准的标准化。本研究的目的是评估使用 aTPS 治疗 HS-WBRT 的可行性,并观察是否可以达到并改善 RTOG 0933 的剂量限制。
本研究纳入了 10 例接受 HS-WBRT 治疗的连续患者。根据 RTOG 0933 方案,10×3 Gy 处方剂量用于 92%的靶体积(全脑,海马除外,三维方向扩展 5mm)。与 RTOG 0933 不同的是,正常脑组织允许的最大点剂量明显降低,并限制在 36.5 Gy。所有患者均采用容积调强弧形治疗(VMAT)技术,使用 4 个弧进行计划。计划使用 Auto-Planning(AP)(飞利浦放射肿瘤学系统)进行优化,采用单一的 AP 模板和优化。
所有 RTOG 0933 试验的限制都得到了满足。最大脑 2%剂量显著改善,降低了 4 Gy(33.5 Gy 与 RTOG 37.5 Gy),海马最小剂量降低了 10%(8.1 Gy 与 RTOG 9 Gy)。在海马周围实现了陡峭的剂量梯度,距离海马 0.5-1cm 处的平均剂量为 27.3 Gy。优化计划的有效工作时间保持在 6'以下。
HS-WBRT 的自动化治疗计划能够满足 RTOG 0933 研究的所有建议,同时显著提高剂量均匀性,减少正常脑内不必要的热点。通过这种方法,实现了计划质量的标准化,并最大限度地减少了计划优化所需的有效时间。